Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Progress Software to Report Fourth Quarter and Fiscal Year 2023 Financial Results on January 16, 2024
-
Tome Biosciences Acquires Replace Therapeutics
-
DIVERGENT Energy Services Announces Closing of Shares for Interest Transaction
-
Expanding Brands Smoothly: J.R Promotions Launches Brand Ambassador Service
-
Wolf Greenfield Promotes Four Attorneys in 2024
-
MarketGap Announces Enhancements to its Amazon FBA Calculator to Offer Precise Calculations for Amazon Business Owners
-
NBT Bancorp Inc. Announces Date of Fourth Quarter Conference Call
-
Check Point Software to Announce Fourth Quarter and Full Year 2023 Financial Results on February 6, 2024
-
Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
-
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The Fiscal Year Ended December 31, 2023, Based On Currently Available Information
-
BayFirst Financial Corp. Appoints Thomas G. Zernick as CEO and Names Robin Oliver as President, Effective January 1, 2024
-
Blink Charging Celebrates a Strong 2023, Setting Up for a Prosperous 2024
-
180 Degree Capital Corp. Notes the Start of Discount Management Program First Measurement Period
-
Kovo HealthTech Partners with CareCloud for Electronic Health Records, Practice Management, and Credentialing Support
-
Innovator Expands Defined Protection ETF Suite with AJAN Following Market Demand
-
National Academy of Sports Medicine® (NASM) Streamlines the Path to Physique and Bodybuilding Excellence with a New Course: Bodybuilding Meal Prep Made Easy
-
Precipio Announces Christina Valauri joins the Board of Directors
-
Fortinet to Announce Fourth Quarter and Full Year 2023 Financial Results
-
Quadient Announces Appointment of New Chief Marketing Officer, Petra Wolf
-
First Trust Portfolios Canada Announces Name Change for First Trust Buffer ETFs
-
AS Tallink Grupp: Managers’ Transactions
-
TQRP: A Catalyst for Change and Educational Equity
-
Notification of managers and closely related parties’ transactions with A.P. Møller - Mærsk A/S shares in connection with share buy-back program
-
Global Technologies, Ltd. Enters into Letter of Intent to Acquire EV Space Company, GOe3, LLC
-
KULR to Introduce KULR ONE MAX at CES 2024
-
MILLER/HOWARD HIGH INCOME EQUITY FUND DECLARES MONTHLY DISTRIBUTIONS
-
Alliance Trust PLC - Total Voting Rights
-
Precipice Holdings Limited Acquires Common Shares of Nova Leap Health Corp.
-
AITX Forecasts 2x to 4x Annual Recurring Revenue Sales Growth in Calendar 2024
-
Flash News: OKX Wallet Increases rewards for Cryptopedia Season 8 with ZetaChain Wave 2
-
Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients
-
Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
-
Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
-
Stronghold Announces Addition of up to ~1 EH/s Through Bitcoin Miner Purchases and an Option to Purchase Bitcoin Miners
-
Dianthus Therapeutics to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
-
Lands’ End Announces New Term Loan
-
Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference
-
Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer
-
Xactly’s 2024 Sales Compensation Report Reveals Top Challenges in Achieving Revenue Growth
-
Coherus Announces U.S. Launch of LOQTORZI™
-
Form 8.3 - Young & Co's Brewery plc
-
urban-gro, Inc. Secures Design-Build Contract Valued at Approximately $20 Million
-
Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections
-
Experience FITE: Transforming CeFi with Innovative Reward Strategies
-
UNISYNC Reports Fiscal 2023 Financial Results
-
Intra-Cellular Therapies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer
-
The Chefs’ Warehouse, Inc. to Participate in the 2024 ICR Conference
-
Asia Pacific Wire & Cable Corporation Limited Reports Third Quarter 2023 Financial Results
-
Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing
